DOD Biotech PCL (BKK:DOD) Operating Margin %: -10.42% (As of Mar. 2026)


BKK:DOD DOD Biotech PCL BKK:DOD
76 GF Score
Price ฿1.50
GF Value ฿1.67
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is DOD Biotech PCL Operating Margin %?

DOD Biotech PCL BKK:DOD 76 Operating Margin % is -10.42% as of Mar. 2026. GuruFocus rates BKK:DOD with a GF Score™ of 76/100 and a GF Value™ of ฿1.67 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 1,951 Consumer Packaged Goods companies, DOD Biotech PCL ranks worse than 70.63% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. DOD Biotech PCL's Operating Income for the three months ended in Mar. 2026 was ฿-12.5 Mil. DOD Biotech PCL's Revenue for the three months ended in Mar. 2026 was ฿119.9 Mil. Therefore, DOD Biotech PCL's Operating Margin % for the quarter that ended in Mar. 2026 was -10.42%.

The historical rank and industry rank for DOD Biotech PCL's Operating Margin % or its related term are showing as below:

BKK:DOD' s Operating Margin % Range Over the Past 10 Years
Min: -2.12   Med: 21.93   Max: 46.3
Current: 1.65


BKK:DOD's Operating Margin % is ranked worse than
70.63% of 1951 companies
in the Consumer Packaged Goods industry
Industry Median: 5.26 vs BKK:DOD: 1.65

DOD Biotech PCL's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

DOD Biotech PCL's Operating Income for the three months ended in Mar. 2026 was ฿-12.5 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was ฿9.2 Mil.


DOD Biotech PCL  (BKK:DOD) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


DOD Biotech PCL Operating Margin % Related Terms


DOD Biotech PCL Operating Margin % Historical Data

* Premium members only.

The historical data trend for DOD Biotech PCL's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DOD Biotech PCL Operating Margin % Chart

DOD Biotech PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.61 -2.12 13.24 2.24 6.46

DOD Biotech PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.31 6.50 6.88 1.33 -10.42

BKK:DOD vs KHC, GIS: Operating Margin % Comparison

For the Packaged Foods subindustry, DOD Biotech PCL's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DOD Biotech PCL Operating Margin % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, DOD Biotech PCL's Operating Margin % distribution charts can be found below:

* The bar in red indicates where DOD Biotech PCL's Operating Margin % falls into.


BKK:DOD
76GF Score
DOD Biotech PCL BKK:DOD
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DOD Biotech PCL Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

DOD Biotech PCL's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=39.321 / 608.984
=6.46 %

DOD Biotech PCL's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=-12.496 / 119.906
=-10.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -10.42% mean?
DOD Biotech PCL (BKK:DOD) has a Operating Margin % of -10.42% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on DOD Biotech PCL and its competitors. According to the industry distribution chart, DOD Biotech PCL ranks #1378 out of 1951 companies in the Consumer Packaged Goods industry, placing it in the top 70.6%.
Is DOD Biotech PCL's Operating Margin % too high?
DOD Biotech PCL's current Operating Margin % is -10.42%. Based on the distribution chart, DOD Biotech PCL ranks #1378 out of 1951 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, DOD Biotech PCL has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DOD Biotech PCL's Operating Margin % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, DOD Biotech PCL ranks #1378 out of 1951 companies for Operating Margin %. This places DOD Biotech PCL in the lower half of its industry. The industry median Operating Margin % is 5.26. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Consumer Packaged Goods company?
The median Operating Margin % among Consumer Packaged Goods companies is 5.26, based on 1,951 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on DOD Biotech PCL and its competitors. For the Consumer Packaged Goods industry, the median Operating Margin % is 5.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DOD Biotech PCL's current Operating Margin % is -10.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DOD Biotech PCL stock overvalued right now?
Based on GuruFocus' analysis, DOD Biotech PCL (BKK:DOD) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿1.67, compared to a current price of ฿1.50 — trading 10.2% below its estimated fair value. The current Operating Margin % is -10.42%. DOD Biotech PCL's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For DOD Biotech PCL (BKK:DOD), the current Operating Margin % is -10.42% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DOD Biotech PCL (BKK:DOD) Overvalued in 2026?

Based on GuruFocus' analysis, DOD Biotech PCL stock appears to be undervalued. The current stock price of ฿1.50 is trading 10.2% below its estimated GF Value™ of ฿1.67. GuruFocus considers DOD Biotech PCL to be Modestly Undervalued.

Key valuation signals for BKK:DOD:

  • Operating Margin %: -10.42%
  • GF Value™: ฿1.67 vs. price of ฿1.50 (10.2% below fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the BKK:DOD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DOD Biotech PCL Business Description

Address No. 111, Moo 2, Tumbol Taa jeen, Amphor Muengsamutsakhon, Samut Sakhon, THA, 74000
DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The group is principally engaged in the supplement business. Its operations are carried on only in Thailand. Its products include: Capsule; Gel; Jelly; Powder for making drinks; Concentrated water extract (Shot Drink); Softgel; Tablet; Probiotics; Gummies; and Direct-to-Mouth Packaging.
76GF Score

Get the complete analysis for BKK:DOD

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿1.50
Price
฿1.67
GF Value